Therapeutic plasma exchange and IVIG can significantly reduce biological age
Live Forever Club - 20-Aug-2024How TPE and IVIG could unlock the fountain of youth
Join the club for FREE to access the whole archive and other member benefits.
Director of the Buck Artificial Intelligence Platform & Stanford 1000 Immunomes Project
David is the Director of the Stanford 1000 Immunomes Project, Associate Professor at the Buck Institute for Research on Aging, and co-founder at Edifice Health. He received his PhD in Human Biochemistry from the University of Buenos Aires, Argentina, in 2008. His research is focused on better understanding the aging of the immune system. Using the Influenza, A model, David’s research is focused in elucidating the cellular and molecular mechanisms of human immune-senescence to define immunological ‘metrics’ of human health. During his Postdoc, he conducted cutting-edge research in Data Science and Systems Immunology to answer scientific questions with strong potential for translational medicine, including the effect of immunity in aging and age-related disease. Advances in these areas will provide for improved diagnostic monitoring and therapeutic interventions that will significantly improve the health and lives of many people.
Visit website: https://www.buckinstitute.org/lab/furman-lab/
See also: Buck Institute - Independent biomedical research institute focused on aging
Details last updated 08-Oct-2020
31-May-2023 to 02-Jun-2023
Event about aging and aging related diseases organized by Hanson Wade
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
17-Apr-2023 to 19-Apr-2023
3-day health summit encouraging unique networking opportunities for industry professionals organized by The HEALinc
14-Nov-2022
Event about Healthy longevity innovation mission by Collider Health (FREE)
10-Oct-2022 to 13-Oct-2022
The Kitalys Institute virtual conference about going beyond treating individual diseases to extending healthy lifespan
03-Dec-2024 to 04-Dec-2024
Longevity researchers, investors, and entrepreneurs speaking about eliminating disease of ageing by Longevity Global (Novato, CA, USA)
How TPE and IVIG could unlock the fountain of youth
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Measuring immune health with a chemokine, CXCL9, for early disease interventions
Caffeine may reduce chronic inflammation linked to age-related diseases